SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001570562-21-000064
Filing Date
2021-02-23
Accepted
2021-02-23 09:04:04
Documents
16
Period of Report
2021-02-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eols-20210223.htm   iXBRL 8-K 33714
2 EX-99.1 ex991022321.htm EX-99.1 19241
8 image1a.jpg GRAPHIC 10429
  Complete submission text file 0001570562-21-000064.txt   218080

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20210223.xsd EX-101.SCH 2430
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eols-20210223_cal.xml EX-101.CAL 718
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eols-20210223_def.xml EX-101.DEF 1655
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20210223_lab.xml EX-101.LAB 24975
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20210223_pre.xml EX-101.PRE 13195
9 EXTRACTED XBRL INSTANCE DOCUMENT eols-20210223_htm.xml XML 11034
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

IRS No.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38381 | Film No.: 21663286
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences